Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease

A series of iminosugars bearing two or three alkyl chains ('iminoglycolipids') were designed as ceramide mimics and analogues of N-butyl 1-deoxynojirimycin (N-Bu DNJ, Zavesca®). This orally active iminosugar inhibits the biosynthesis of glucosylceramides, which accumulate pathologically in...

書誌詳細
主要な著者:	Boucheron, C, Desvergnes, V, Compain, P, Martin, O, Lavi, A, Mackeen, M, Wormald, M, Dwek, R, Butters, T
フォーマット:	Journal article
言語:	English
出版事項:	2005

類似資料

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease (vol 16, pg 1747, 2005)
著者:: Boucheron, C, 等
出版事項: (2005)

Erratum: Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: The search for new therapeutic agents against Gaucher disease (Tetrahedron: Asymmetry (2005) 16 (1747) DOI: 10.1016/j.tetasy.2005.03. 015)
著者:: Boucheron, C, 等
出版事項: (2005)

Can P-glycoprotein influence the bioavailability of iminosugar-based glucosylceramide synthase inhibitors?
著者:: Norris-Cervetto, E, 等
出版事項: (2006)

Selective Targeting of the Interconversion between Glucosylceramide and Ceramide by Scaffold Tailoring of Iminosugar Inhibitors
著者:: Cécile Baudoin-Dehoux, 等
出版事項: (2019-01-01)

Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease.
著者:: Karen M Ashe, 等
出版事項: (2011-01-01)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
著者:: Butters, T, 等
出版事項: (2005)

Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
著者:: Norris-Cervetto, E, 等
出版事項: (2004)

Iminosugars : from synthesis to therapeutic applications /
著者:: Compain, Philippe, 等
出版事項: (2007)

Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity.
著者:: Gerrard, G, 等
出版事項: (2009)

Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brain
著者:: Scott D. Larsen, 等
出版事項: (2012-02-01)

Quantification of glucosylceramide in plasma of Gaucher disease patients
著者:: Maria Viviane Gomes Muller, 等
出版事項: (2010-12-01)

Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease.
著者:: Mario A Cabrera-Salazar, 等
出版事項: (2012-01-01)

Iminosugars and methods of treating Arenaviral infections
著者:: Ramstedt, U, 等
出版事項: (2010)

Iminosugars and methods of treating viral diseases
著者:: Ramstedt, U, 等
出版事項: (2011)

Iminosugars and methods of treating Filoviral diseases
著者:: Ramstedt, U, 等
出版事項: (2011)

Iminosugar antivirals: the therapeutic sweet spot
著者:: Alonzi, D, 等
出版事項: (2017)

Iminosugars and methods of treating Bunyaviral and Togaviral diseases
著者:: Ramstedt, U, 等
出版事項: (2010)

Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model.
著者:: Sonya Barnes, 等
出版事項: (2014-01-01)

Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth.
著者:: A Abe, 等
出版事項: (1995-03-01)

Glucosylceramide modulates membrane traffic along the endocytic pathway.
著者:: Sillence, D, 等
出版事項: (2002)

Iminosugars as therapeutic agents: recent advances and promising trends.
著者:: Nash, R, 等
出版事項: (2011)

Glucosylceramide modulates membrane traffic along the endocytic pathway
著者:: Dan J. Sillence, 等
出版事項: (2002-11-01)

Fluorescence HPLC Analysis of the in-vivo Activity of Glucosylceramide Synthase
著者:: Kartik Roy, 等
出版事項: (2019-06-01)

Docking study and biological evaluation of pyrrolidine-based iminosugars as pharmacological chaperones for Gaucher disease
著者:: Kato, A, 等
出版事項: (2016)

Conformationally constrained fused bicyclic iminosugars: synthetic challenges and opportunities
著者:: Raphaël Hensienne, 等
出版事項: (2019-02-01)

Glucosylceramide synthetase inhibitors sensitise B-CLL cells to cytotoxic agents without reversing P-gp functional activity.
著者:: Gerrard, G, 等
出版事項: (2004)

Imino sugar therapy for type 1 Gaucher disease.
著者:: Priestman, D, 等
出版事項: (2000)

Gaucher disease.
著者:: Butters, T
出版事項: (2007)

Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells
著者:: Zoran V. Popovic, 等
出版事項: (2017-07-01)

Glucosylceramide synthase in the fat body controls energy metabolism in Drosophila[S]
著者:: Ayako Kohyama-Koganeya, 等
出版事項: (2011-07-01)

ARF6 regulates neuron differentiation through glucosylceramide synthase.
著者:: Lu Li, 等
出版事項: (2013-01-01)

Glucosylceramide synthesis and synthase expression protect against ceramide-induced stress
著者:: Yoshikazu Uchida, 等
出版事項: (2002-08-01)

Studies of the pathogenesis of Gaucher's disease: tissue distribution and biliary excretion of [14C]L-glucosylceramide in rats
著者:: T Tokoro, 等
出版事項: (1987-08-01)

Iminosugar for treatment of tumors
著者:: Dwek, R, 等
出版事項: (2008)

Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
著者:: Durantel, D, 等
出版事項: (2001)

Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury
著者:: Tess V. Dupre, 等
出版事項: (2017-07-01)

A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy
著者:: Mali Cosden, 等
出版事項: (2021-11-01)

Use of iminosugar derivatives to inhibit ion channel activity
著者:: Zitzmann, N, 等
出版事項: (2004)

Glucosylceramide flippases contribute to cellular glucosylceramide homeostasis
著者:: Natsuki Kita, 等
出版事項: (2024-03-01)

Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis.
著者:: Walden, C, 等
出版事項: (2007)